Table 1.
Baseline demographic and clinical characteristics of study participants
| Total N = 39 |
Group 1 N = 12 |
Group 2 N = 12 |
Group 3 N = 3 |
Group 4 N = 12 |
|
|---|---|---|---|---|---|
| Age (years) | 20 | 21 | 20 | 20 | 20 |
| Median | |||||
| (IQR) | (20–1) | (20–21) | (20–21) | (19–20) | (20–22.5) |
| BMI | 19.4 | 18.7 | 19.5 | 19.1 | 20.0 |
| Median | |||||
| (IQR) | (18.3–20.3) | (17.9–0.3) | (18.4–20.2) | (18.3–21.6) | (18.4–20.7) |
| QFT test | N/A | Negative | Negative | Negative | Positive |
| (IU/ml) | 0.011 | 0.038 | 0.083 | 11.8 |
BMI Body Mass Index, IQR interquartile range, QFT QuantiFERON-TB Gold-in-tube test